Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

106.91
Delayed Data
As of 4:00pm ET
 -4.29 / -3.86%
Today’s Change
60.27
Today|||52-Week Range
112.43
+46.63%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close111.20
Today’s open111.20
Day’s range105.69 - 112.43
Volume1,490,010
Average volume (3 months)724,749
Market cap$10.2B
Data as of 4:00pm ET, 11/22/2019

Growth & Valuation

Earnings growth (last year)-39.67%
Earnings growth (this year)-4.62%
Earnings growth (next 5 years)+23.42%
Revenue growth (last year)-16.69%
P/E ratioNM
Price/Sales97.91
Price/Book7.13

Competitors

 Today’s
change
Today’s
% change
GLPGGalapagos NV0.000.00%
BHCValeant Pharmaceutic...-0.17-0.61%
MYLMylan NV-0.03-0.17%
IONSIonis Pharmaceutical...+1.05+1.74%
Data as of 6:30pm ET, 11/22/2019

Financials

Next reporting dateFebruary 6, 2020
EPS forecast (this quarter)-$2.22
Annual revenue (last year)$74.9M
Annual profit (last year)-$761.5M
Net profit margin-1,016.58%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cambridge, Massachusetts

Forecasts